Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002317.SZ

Guangdong Zhongsheng Pharmaceutical Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2023: 822,728,687

Guangdong Zhongsheng Pharmaceutical Co., Ltd. Shares (Diluted, Weighted) is 822,728,687 for the year ending December 31, 2023, a 2.19% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

Guangdong Zhongsheng Pharmaceutical Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2022 was 805,125,710, a 0.97% change year over year.
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2021 was 797,430,076, a -0.74% change year over year.
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2020 was 803,357,169, a 0.00% change year over year.
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2019 was 803,357,169, a -2.27% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

Shenzhen Stock Exchange: 002317.SZ

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

CEO	Mr. Yong Hong Chen
IPO Date	Dec. 11, 2009
Location	China
Headquarters	Information Industry Park
Employees	1,732
Sector	Health Care
Industries Pharmaceuticals

Description

Guangdong Zhongsheng Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. The company offers Chinese and chemical medicines. It is also involved in the research and development of products in the fields of ophthalmology, cardiovascular, cerebrovascular, respiratory, digestive, diabetes, tumor, and senile degenerative diseases. The company was founded in 1979 and is based in Dongguan, China.

Key trends

Past 5 years